7.3 Chronic Pain Flashcards

(136 cards)

1
Q

Definitions of some chronic pain states

Allodynia

A

Allodynia

Pain due to a stimulus which
does not normally provoke pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dysaesthesia

A

Dysaesthesia

An unpleasant abnormal sensation,
whether spontaneous or evoked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hyperaesthesia I

A

Hyperaesthesia

Increased sensitivity to stimulation, excluding the special senses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hyperalgesia

A

Hyperalgesia
An increased response to a stimulus which is normally painful

may be caused by damage to nociceptors or peripheral nerves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Primary hyperalgesia

what is it

how does it occur

A

Primary hyperalgesia

describes pain sensitivity that occurs

directly in the damaged tissues.

This occurs by peripheral sensitisation whereby
nociceptors exhibit reduction in threshold and an increase in responsiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Secondary hyperalgesia

what is it

How does it occur

A

Secondary hyperalgesia

describes pain sensitivity that occurs in
surrounding or distant undamaged tissues.

This is a result of central sensitisation

wherein there is an increase in the excitability of
neurons within the central nervous system, so that normal inputs begin to produce abnormal responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mechanisms involved in hyperalgesia

Peripheral sensitisation

A

Abnormal nociceptor sensitivity

Spontaneous neuronal activity
and axonal sprouting

Inflammatory mediator-induced
excitation of nociceptors

Sympathetically mediated pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanisms involved in hyperalgesia

Central sensitisation

A

Short-term homosynaptic potentiation
(wind-up)

Long-term homosynaptic potentiation
(through NMDA and AMPA receptors)

Changes in synaptic architecture

Loss of inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pain scales for assessment of chronic pain

A

Global Impression Of Change Scale

Brief Pain Inventory

Short Form – 36 Physical Function Scale

Roland Morris Questionnaire

Health Assessment Questionnaire

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Brief Pain Inventory

A

Brief Pain Inventory

Worst, best and present pain intensity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Short Form – 36 Physical Function Scale

A

Short Form – 36 Physical Function Scale

General measure that is
intended to capture quality of life as well as
whether an individual is healthy or not

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Global Impression Of Change Scale

A

Global Impression Of Change Scale

Completed by both the patient
and the
clinician

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Roland Morris Questionnaire

A

Roland Morris Questionnaire

Back/leg pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Health Assessment Questionnaire

A

Health Assessment Questionnaire

Difficulty rating of activities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Syndrome-specific pain scales

A

Galer Neuropathic Pain Score

Oswestry Disability Questionnaire

American College of Rheumatology Response Criteria

Arthritis Impact Measurement Scale

Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Galer Neuropathic Pain Score

A

Galer Neuropathic Pain Score

For neuropathic pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Oswestry Disability Questionnaire

A

Oswestry Disability Questionnaire

For patients with back pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

American College of Rheumatology Response Criteria

A

American College of Rheumatology Response Criteria

Rheumatoid arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Arthritis Impact Measurement Scale

A

Arthritis Impact Measurement Scale

Osteoarthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index

A

Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index

Osteoarthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Psychological assessment

A

McGill Pain Questionnaire

Beck’s Depression Inventory

Sickness Impact Profile

Minnesota Multiphasic Personality Inventory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

McGill Pain Questionnaire

A
Domains: 
sensory, 
affective,
 evaluative 
and miscellaneous
 plus a painintensity
five-point scale
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Beck’s Depression Inventory

A
A 21-item self-rating scale 
that measures the severity of 
key symptoms associated with 
clinical depression 
but not with other psychological
factors aggravating pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Sickness Impact Profile

A
It is a general indicator of health status 
and health-related
dysfunction rather than pain
Best studied in the population 
with chronic back pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Minnesota Multiphasic Personality Inventory
This is a self-administered true–false test . The questionnaire consists of 567 items and it places patients in one of four groups: hypochondriacal, reactively depressed, ‘somaticisers’ and manipulators
26
Glutamate receptors where activation
Glutamate receptors (AMPA and NMDA) have been identified in spinal cord.
27
NMDA role chronic pain
Activation of these receptors by nociceptive inputs from periphery is involved in development of chronic pain. Hence, NMDA antagonists such as ketamine are used to treat certain chronic pain states.
28
Wind up phenomena | Central sensitisation
Persistent nociceptive stimulation of C fibres produces hyperalgesia and allodynia through wind-up phenomena and central sensitisation.
29
Axonal sprouting and neuroma formation
Axonal sprouting and neuroma formation subsequent to nerve injury exhibit altered up- regulation of sodium channels, and down-regulation of potassium channels. The net result is increased neuronal excitability.
30
Is there any phenotypic switching
Lastly, sensory Aβ undergo phenotypic switching to C fibres and start conducting pain.
31
Low-back pain
lumbosacral region arising from the spinal or paraspinal structures
32
Sciatica
(radicular leg pain) may accompany low back | pain but is regarded as a separate entity
33
Is LBP commong
About 50%–80% of adults experience low-back pain. ``` Most backaches (85%–90%) are simple low-back pain (mechanical back pain) in which no particular pathology exists ```
34
Nonmechanical backaches may be due
Nonmechanical backaches may be due to more serious conditions like cancer, infection or inflammatory arthritis. Visceral pathologies may also lead to low back pain.
35
Causes of low-back pain Mechanical
Mechanical ``` Lumbar strain or sprain Degenerative disease Spondylosis Spondylolysis Spondylolisthesis Disc herniation Facet joint arthropathy Spinal stenosis Osteoporosis ```
36
Non-mechanical (spinal pathology)
Non-mechanical (spinal pathology) Tumours Infection Arthritis
37
Back pain ‘Red flag’ signs
‘Red flag’ signs: non-mechanical pain, thoracic pain, history of cancer, HIV, weight loss, structural deformity, young (< 20 years) or old (> 55 years), recent trauma, osteoporosis, night pain and bladder/bowel dysfunction.
38
Back pain Imaging:
Imaging: should be done only if the history or clinical examination is suggestive of non-mechanical back pain
39
Back pain Management
Management: mostly early mobilisation and pain relief. Physiotherapy may be needed if progress is slow. A minority will need further evaluation and management.
40
spinal disc herniation
affecting the spine due to tear in the outer, fibrous ring (annulus fibrosus) of an intervertebral disc allowing nucleus pulposus to bulge out beyond the damaged outer rings
41
spinal disc herniation Is severe pain nerve root compression
This tear causes release of inflammatory chemical mediators which may directly cause severe pain, even in the absence of nerve root compression.
42
spinal disc herniation result d/t Commonest sites x2 rare @
They most often result due to wear and tear, and occur most frequently at L4–L5 or L5–S1 levels. ``` The second most common site is lower cervical (C5–C6 or C6–C7), ``` while it is uncommon at thoracic levels.
43
spinal disc herniation worsened by what positon
The sitting and bending forward position (associated with desk jobs) cause the highest increases in intradiscal pressures predisposing to prolapse.
44
Neurology in a severe lumbar disc prolapse L2
L2 Hip flexion (iliopsoas) Groin
45
Neurology in a severe lumbar disc prolapse L3
L3 Knee extension (quadriceps) Anterolateral thigh Patellar reflex lost
46
Neurology in a severe lumbar disc prolapse L4
L4 ``` Heel walking (ankle dorsiflexors) ``` Medial ankle Patellar reflex lost
47
Neurology in a severe lumbar disc prolapse L5
L5 First-toe dorsiflexion Dorsum of foot
48
Neurology in a severe lumbar disc prolapse S1
S1 Toe walking (ankle plantar flexors) Lateral foot surface Ankle reflex lost
49
Neurology in a severe lumbar disc prolapse Cauda equina
Cauda equina Ankle weakness Lax anal sphincter Paresthesia of leg and perineum Ankle reflex lost
50
Neurology in a severe cervical disc prolapse C5
C5 ``` Arm abduction (deltoid) and elbow flexion (biceps) ``` Shoulder area and outer upper arm Biceps
51
Neurology in a severe cervical disc prolapse C6
C6 ``` Elbow flexion (biceps) Wrist extension ``` Index finger Brachioradialis
52
Neurology in a severe cervical disc prolapse C7
C7 Elbow extension (triceps) Wrist flexion Finger extension Middle finger Triceps
53
Neurology in a severe cervical disc prolapse C8
C8 Finger flexion and adduction Little finger
54
Neurology in a severe cervical disc prolapse T1
T1 Finger abduction Lateral epicondyle
55
Regarding lumbar facet arthropathy
causes 15%–40% of cases of low-back pain due to dysfunction or inflammation of the facet (zygapophyseal) joints
56
facet (zygapophyseal) joints What makes up the joint
These joints are formed by the articulation of the articular processes of the adjacent vertebrae. They are innervated by two medial branches of the dorsal rami of the corresponding spinal nerves
57
Facet joint pain Describe pain
The patient complains of deep, achy, non-specific low-back pain localised over the affected facet joint.
58
Facet joint pain Radiation?
Radiation to the thigh is possible, but radiation | distal to the knee is uncommon.
59
Facet joint pain worsened by
The pain is worse with lumbar extension, extensive walking or sitting for long periods of time. The bowel and bladder are not involved.
60
Facet joint pain examination palpation changes
On examination, there is pain with deep palpation over the affected facet joint. Paraspinal muscle spasm, loss of lumbar lordosis and limited extension of spine may be noted.
61
Facet joint pain Diagnosis
However, historic or physical examination findings cannot reliably diagnose lumbar zygapophyesal joint pain. The most accepted method for diagnosing pain arising from the lumbar facet joints is with low-volume intra-articular injections or medial branch blocks.
62
Diagnostic blocks
Diagnostic blocks use only local anaesthetics, and analgesics (opioids) for sedation must be avoided.
63
Lumbar spinal stenosis mcq bit about walking
Walking uphill is easier than walking on a flat surface
64
Lumbar spinal stenosis is the
Lumbar spinal stenosis is the narrowing of the spinal canal (transforaminal canal), resulting in nerve compression of the spinal roots laterally
65
Lumbar spinal stenosis Affects usually symptoms
It usually affects middle-age patients (> 55 years). Symptom include leg pain, weakness, paraesthesia and radicular pain of the involved spinal root.
66
Is it the same as intermittent claudication
similar to vascular claudication, but different in many respects, hence it is called pseudoclaudication or neurogenic claudication
67
Types of claudication and factors affecting them Neurogenic claudication Vascular claudication Aggravating factors
Aggravating factors ``` Neuro - Extension of spine: standing walking hyperextension of spine ``` IC Any leg exercise
68
Types of claudication and factors affecting them Neurogenic claudication Vascular claudication Relieving factors
Relieving factors ``` Neuro Flexion of spine: squatting/sitting bending forward when sitting walking uphill rather than on flat level lying on side rather than on back easier to cycle than to walk ``` IC Rest
69
Types of claudication and factors affecting them Neurogenic claudication Vascular claudication Other features
Other features Pulse: usually normal Skin changes: usually absent Autonomic disturbances: rare IC Vascular changes: blood pressure decreased peripheral pulses weak or absent bruits or murmurs Skin changes: pallor cyanosis nail dystrophy Autonomic: impotence
70
sacroiliac joint pain innervation
sacroiliac joint (SIJ) is innervated posteriorly by lateral branches of the dorsal primary rami of L4–S3 and
71
sacroiliac joint pain innervation
anteriorly by lateral branches of the dorsal primary rami of L2–S2.
72
sacroiliac joint pain
SIJ pain accounts for 16%–30% of cases of chronic mechanical low-back pain.
73
SIJ pain mainly involve a/w any conditions?
SIJ pain mainly involves the buttocks, although it may be referred to the thigh, abdomen, groin or legs. It may also occur with systemic conditions such as ankylosing spondylitis, Crohn’s disease and gout
74
SIJ pain exacerbating / relieving
pain is worse in the morning and can be exacerbated by spine flexion, prolonged sitting and weight bearing on the painful limb. Symptoms may be relieved by flexing the affected leg and weight bearing on the contralateral leg.
75
SIJ Pain Provocative manoeuvre to help distinguise is it imaged?
Different provocative manoeuvres help distinguish this condition from others causing low back pain. Most commonly used is the FABER ``` (flexion, abduction, external rotation, and extension of the hip to create a figure of four: elicits pain) Patrick test. ``` This is used to increase the predictive value and establish the diagnosis. Radiological imaging is used mainly to exclude red flags. Lasègue’s sign is not seen in SIJ pain
76
SIJ Pain
Treatment follows a multidisciplinary approach. Conservative treatments include exercise therapy and manipulation (address gait and posture imbalance). Intra-articular SJ infiltrations with local anaesthetic and corticosteroids have been found to be effective in most studies.
77
The piriformis is a muscle where Function
The piriformis is a muscle in the gluteal region of the lower limb. The piriformis muscle is part of the lateral rotators of the hip and it externally rotates the extended thigh and abducts the flexed thigh.
78
piriformis syndrome causes
In about 15% of patients, the piriformis muscle is split and pierced by the two components of sciatic nerve. At other times, overuse injury (common in cyclists, runners, tennis players, ballet dancers) of this muscle may cause symptoms.
79
Piriformis syndrome symptoms worsened
This causes sciatic compression and consequent sciatica (pain in the distribution of sciatic nerve). Pain worsens on squatting, climbing stairs, walking and prolonged sitting. It is typically unilateral
80
Piriformis syndrome eponymous tests
Diagnostic tests include: Pace sign: pain and weakness on resisted abduction of flexed thigh in seated position. Lasègue’s sign: pain on flexion, adduction and internal rotation of hip in a supine patient. Freiberg’s sign: pain on forced internal rotation of the extended thigh.
81
Piriformis syndrome Rx
Conservative management comprises analgesics, stretching exercises and deep heat using ultrasound. Fluoroscopy-guided piriformis injections using local anaesthetics and corticosteroids are effective. Botulinum toxin injections have shown more effective pain relief. Surgical release is the last option
82
intravenous drug infusion therapy | for treatment of neuropathic pain
``` 1 uses lignocaine (Na+ channel blocker), ``` 2 ketamine (NMDA antagonist), 3 magnesium (NMDA antagonist), 4 adenosine (presynaptic antinociception by preventing release of substance P) 5 alfentanil (opioid)
83
Phentolamine infusion used for
Phentolamine (α-blocker) infusion is used as a diagnostic test for sympathetic mediated pain. If positive, the patient is prescribed oral α- blocker such as doxazocin
84
Fibromyalgia syndrome
chronic generalised pain and allodynia, ``` a heightened and painful response to pressure (tender points) ```
85
Fibromyalgia syndrome sy
symptoms may ``` include fatigue, sleep disturbance, joint stiffness, bowel and bladder abnormalities, paraesthesia, depression and anxiety. ```
86
Fibromyalgia syndrome sy prevelance
It is estimated to affect 2%–4% of the population and is more common in females
87
FM Diagnosis
The American College of Rheumatology (ACR 1990) established criteria for the diagnosis of FMS, including the presence of tenderness at 11 or more of 18 preselected sites (tender points). Additionally, the Fibromyalgia Impact Questionnaire is used to assess the impact of pain on a patient’s life.
88
FM rx
A multidisciplinary treatment programme combining behavioural modification, education and physical training is effective
89
Post-herpetic neuralgia is a what is it?
Post-herpetic neuralgia is a debilitating neuralgia following an acute varicella zoster infection (usually after 6 weeks).
90
Post-herpetic neuralgia where Easy to Rx?
Typically, it is confined to a dermatomal distribution of the skin. It is difficult to treat once established. Hence both childhood vaccination and early, aggressive treatment of acute herpes zoster infection are vital.
91
Post-herpetic neuralgia Rx options
1 Since it is a neuropathic pain, it is treated first with antidepressants (tricyclic antidepressants like amitryptyline) followed by anticonvulsants (gabapentin). 2 Opioids may be needed in some (NSAIDs are rarely useful). 3 Topical local anaesthetics and capsaicin may also relieve pain. 4 Intrathecal methylprednisolone with lignocaine as repeated injection can help where non-interventional therapies fail.
92
Diabetic neuropathies are thought to result
Diabetic neuropathies are thought to result from microvascular injury involving vasa nervorum, and macrovascular processes of neuronal ischaemia and infarction. Incidence increases with age, duration of diabetes and degree of hyperglycaemia
93
Diabetic neuropathies Rx
Treatments include: tight glycemic control tricyclic antidepressants: amitryptyline selective norepinephrine reuptake inhibitors: duloxetine anticonvulsants: gabapentine and pregabalin analgesics: opioids topical agents: capsaicin cream and lignocaine patches selective serotonin reuptake inhibitors (e.g. fluoxetine) have not been found to be as efficacious.
94
The neuropathic pain ladder is different from the World Health
The neuropathic pain ladder is different from the World Health Organization pain ladder (cancer pain). First line: tricyclic antidepressant or antiepileptic. Second line: tricyclic antidepressant and antiepileptic. Third line: strong opioid plus above, ± invasive procedures.
95
To make the clinical diagnosis of complex regional pain syndrome (CRPS),
the following criteria (Budapest) must be met 1 Continuing pain, which is disproportionate to any inciting event. 2 Must report at least one symptom in three of the four following categories: /Must display at least one sign at time of evaluation in two or more of the following categories Sensory: Vasomotor: Sudomotor/oedema: Motor/trophic: There is no other diagnosis that better explains the signs and symptoms.
96
CRPS symptoms sensory vasomotor sudomotor motor
Sensory: reports of hyperesthesia and/or allodynia Vasomotor: reports of temperature asymmetry and/or skin colour changes and/or skin colour asymmetry Sudomotor/oedema: reports of oedema and/or sweating changes and/or sweating asymmetry Motor/trophic: reports of decreased range of motion and/or motor
97
Must display at least one sign at time of evaluation in two or more of the following categories:
Sensory: evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch and/or temperature sensation and/or deep somatic pressure and/or joint movement) Vasomotor: evidence of temperature asymmetry (> 1°C) and/or skin colour changes and/or asymmetry Sudomotor/oedema: evidence of oedema and/or sweating changes and/or sweating asymmetry Motor/trophic: evidence of decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin).
98
The International Association for the Study in Pain divides CRPS into two types.
The International Association for the Study in Pain divides CRPS into two types. ``` Type I: formerly known as reflex sympathetic dystrophy, or Sudeck’s atrophy, it does not have demonstrable nerve lesions. ``` Type II: formerly called causalgia, it has evidence of obvious nerve damage.
99
pathogenesis of CRPS peripheral
pathogenesis of CRPS may include 1 peripheral mechanisms such as a upregulation of axonal α2 adrenoceptors, rendering them sensitive to catecholamines (hence the term ‘sympathetically mediated pain’) and b denervation hypersensitivity.
100
pathogenesis of CRPS may include central
Central mechanisms such as wind-up and | central sensitisation play an important role.
101
Risk factors for the development | of CRPS
``` include previous trauma, nerve injury, previous surgery, workrelated injury and female sex. ```
102
CRPS mainstay of management.
Physical therapy is the mainstay of management. However, pain precludes this, hence pain relief becomes vital to achieve movement.
103
CRPS Rx sympathetic pain
Sympatholysis using intravenous regional anaesthesia (lignocaine, guanethidine or bretylium) or sympathetic ganglion blocks are commonly employed to address sympathetically mediated pain. Surgical resection and radiofrequency ablation of ganglia have also been tried.
104
Three phenomena occur after amputation
``` Phantom sensation (non-painful paraesthesias) Stump pain (pain in the stump of the amputated limb) Phantom pain (pain in the amputated limb). ```
105
Salient features of phantom pain:
Salient features of phantom pain: Incidence is up to 75% of amputees. May start immediately but usually starts within first week after amputation. Most complain of intermittent pain (few days in a month).
106
phantom pain type | pathogenesis
Pain may be shooting, cramping, burning or aching in nature. Pathogenesis may be related to spinal and cortical reorganisation of neurons.
107
phantom pain RF
Risk factors for development of phantom pain ``` are pre-amputation pain, persistent stump pain, bilateral amputations and lower-limb amputations. ``` Gender and age are not known risk factors.
108
Phantom pain RF Pharm
Pharmacological treatment includes antidepressants, antiepileptics and analgesics.
109
Nonpharmacological Phantom Pain
Nonpharmacological methods include TENS, spinal cord stimulation and biofeedback. Recently ‘Ramachandran mirror box’ therapy has been used to alleviate painful spasms of phantom limb. Note: pre-emptive regional anaesthesia has not been shown to reduce the incidence of phantom limb pain
110
In transcutaneous electrical nerve stimulation (TENS) Theory
Melzack and Wall proposed that the transmission of noxious information (C fibre) could be inhibited by activity in large-diameter peripheral afferents (Aβ fibre) (gate control theory of pain).
111
In transcutaneous electrical nerve stimulation (TENS),
In transcutaneous electrical nerve stimulation (TENS), electric current produced by a device is used to stimulate the nerves for therapeutic purposes (analgesia).
112
Two types of TENS are used.
Conventional TENS Pulsed TENS
113
Conventional TENS
Low intensity, high frequency Mainly for nociceptive pain Perceived as a paraesthesia Relieves pain by a segmental mechanism
114
Pulsed TENS
High intensity, low frequency Mainly for neuropathic pain Perceived as a muscle twitch Works by activating extra segmental descending inhibitory pain pathways
115
Indications TENS
Indications include ``` acute post-operative pain, labour pain, angina, dysmenorrhoea and chronic pain states ```
116
Contraindications TENS
Contraindications include cardiac pacemakers (interference), pregnancy (can stimulate uterine contractions), bleeding diathesis and epilepsy (may induce seizures).
117
Acupuncture theory
Acupuncture is a complementary therapy that originated in China. ``` It assumes that health is achieved by maintaining a ‘balanced state’ of the body, and that disease is the result of an internal imbalance. ``` This imbalance leads to blockage in the flow of qi (vital energy) along pathways known as meridians.
118
Acupuncture proposed MOA
Needling increases the cerebrospinal fluid concentrations of the endogenous opioids. This may be the reason for the analgesia obtained.
119
Acupuncture uses
Acupuncture has been found to be effective for osteoarthritis, chronic neck pain, low-back pain, and postoperative nausea and vomiting. However, it is not more effective than other conventional therapies
120
Spinal cord stimulation (SCS) what is it
Spinal cord stimulation (SCS) is ``` the technique of stimulation of large sensory fibres (Aβ) in dorsal column tracts ``` to mask the pain carried by spinothalamic tracts (based on the gate control theory of pain). However, it may not be the only mechanism.
121
Spinal cord stimulation (SCS) permanent?
It is not destructive, unlike cordotomy, and is reversible
122
Major indications for SCS
Major indications for SCS are neuropathic states like failed back surgery (United States) and ischaemic pain (Europe).
123
Non responsive to SCS Poor candidates?
Nociceptive pain does not respond to SCS. Major psychiatric issues, drug-seeking behaviour, cardiac pacemakers and patients with secondary gain are poor candidates for this technique.
124
Intrathecal drug delivery systems for who
Intrathecal drug delivery systems (IDDSs) are good options for patients who have ineffective pain relief at acceptable oral or transdermal doses, or for those who have intolerable side effects.
125
Intrathecal drug delivery systems commonest indications
``` 1. Cancer pain (most common), ``` 2. chronic non-malignant pain 3. spasticity are three main indications for IDDSs.
126
IDDS Gold standard also used
Morphine is the gold-standard drug used for this. ``` Apart from opioids, clonidine (α2 blocker), ziconitide (Ca+ channel blocker) and local anaesthetics (Na+ channel blocker) are also used. ```
127
IDDS 1st line second ine
First-line drugs include morphine, hydromorphone and ziconitide, whereas fentanyl, clonidine and local anaesthetics are second-line agents.
128
Tolerance and opioid-induced hyperalgesia result from
Tolerance and opioid-induced hyperalgesia result from opioid therapy, but are caused by two distinct mechanisms.
129
Opioid-induced hyperalgesia (OIH)
Opioid-induced hyperalgesia (OIH) is a phenomenon associated with the long-term use of opioids. Over time, individuals develop an increasing sensitivity to noxious stimuli (hyperalgesia), such that a non-noxious stimulus evokes a painful response (allodynia).
130
Mechanisms involved in OIH
Mechanisms involved in OIH are: spinal NMDA activation, spinal dynorphin release (KOP agonist) and facilitation of descending inhibitory pathways
131
OIH Rx options
Treatment options include: reduction of opioid dose opioid rotation to methadone or buprenorphine (KOP antagonist) NMDA antagonists (ketamine).
132
In tolerance,
In tolerance, increasing the dose of opioid can overcome it, but doing so in opioid-induced hyperalgesia may worsen the patient’s condition by inducing hyperalgesia while increasing physical dependence.
133
Tolerance v Pseudotolerance
important to make a clinical distinction between ``` 1 tolerance (reduction in effect needing an increase of opioid dose to maintain pain relief) ``` vs ``` 2 pseudotolerance (request of more opioids by patient as the prevalent dose is insufficient for treating the pain). ```
134
Difference between opioid tolerance and opioid-induced hyperalgesia
Opioid tolerance Due to decreased analgesic potency Down-regulation of anti-nociceptive system Up-regulation of pro-Rightward shift of dose-response curve Responds to dose increase Sensory testing reveals no hyperalgesia
135
Opioid-induced hyperalgesia
Opioid-induced hyperalgesia Due to increased sensitivity (hyperalgesia) Up regulation of pro nociceptive system Downward shift of dose response curve Sensory testing reveals hyperalgesia
136
Risk factors for the development of chronic post-surgical pain (CPSP) are:
1 Age: decreasing incidence with increasing age 2 Preoperative attitude: fear, anxiety or depression 3 Preoperative pain: higher incidence of CPSP 4 Operative technique: invasive and longer surgeries are more associated with CPSP than shorter non-invasive (laparoscopic) procedures 5 Genetic factors 6 Severe acute post-surgical pain 7 Anaesthesia technique: none shown to be superior, but emphasis is on multimodal analgesia with good pain relief provision for subacute post-operative pain as well.